Cargando…

An Analysis of Targeted Serum Lipidomics in Patients with Pneumoconiosis — China, 2022

INTRODUCTION: Pneumoconiosis emerges as the most critical and prevalent occupational disease in China at present, according to research. Studies indicate that pneumoconiosis may indeed impact the body’s phospholipid metabolism. METHODS: In this study, serum samples were taken from 46 paired particip...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenrong, Peng, Fangda, Ding, Chunguang, Li, Tao, Wang, Huanqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560374/
https://www.ncbi.nlm.nih.gov/pubmed/37814648
http://dx.doi.org/10.46234/ccdcw2023.161
_version_ 1785117719954194432
author Wang, Wenrong
Peng, Fangda
Ding, Chunguang
Li, Tao
Wang, Huanqiang
author_facet Wang, Wenrong
Peng, Fangda
Ding, Chunguang
Li, Tao
Wang, Huanqiang
author_sort Wang, Wenrong
collection PubMed
description INTRODUCTION: Pneumoconiosis emerges as the most critical and prevalent occupational disease in China at present, according to research. Studies indicate that pneumoconiosis may indeed impact the body’s phospholipid metabolism. METHODS: In this study, serum samples were taken from 46 paired participants, which included patients with pneumoconiosis and dust-exposed workers. We employed ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) technology in targeted lipidomics to investigate serum target phospholipids. Initially, a pilot study was conducted with a selection of 24 pneumoconiosis patients and 24 dust-exposed workers, using both univariate and multivariate statistical analyses to preliminarily identify significant differences in phospholipids. Subsequent to this, the remaining subjects were engaged in a validation study, wherein receiver operating characteristic (ROC) analysis was performed to further substantiate the screening potency of potential lipid biomarkers for pneumoconiosis. RESULTS: The pilot study revealed significantly reduced serum levels of 16∶0 lysophosphatidylcholines (Lyso PC), 18∶0–18∶1 phosphatidylglycerol (PG), 18∶0–18∶1 phosphatidylethanolamine (PE), 18∶0 PE, and 18∶1 lysophosphatidylethanolamine(Lyso PE) in the case group in comparison to the control group. Additionally, 18∶0 PE, 18∶0–18∶1 PE, and 18∶1 Lyso PE emerged as significant phospholipids with superior diagnostic values [area under the curve (AUC)>0.7]. A diagnostic model was established, built on 16∶0 PC and 18∶0 PE (AUC>0.8). In the ROC analyses of validation studies, the 18∶0–18∶1 PE and this diagnostic model demonstrated excellent screening efficiency (AUC>0.7). DISCUSSION: A significant divergence in phospholipid metabolism has been observed between pneumoconiosis patients and dust-exposed workers. The 18∶0–18∶1 PE present in serum could potentially function as a lipid biomarker for pneumoconiosis. Additionally, diagnostic models were developed relying on 16∶0 PC and 18∶0 PE, proving to have superior screening efficiency.
format Online
Article
Text
id pubmed-10560374
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-105603742023-10-09 An Analysis of Targeted Serum Lipidomics in Patients with Pneumoconiosis — China, 2022 Wang, Wenrong Peng, Fangda Ding, Chunguang Li, Tao Wang, Huanqiang China CDC Wkly Methods and Applications INTRODUCTION: Pneumoconiosis emerges as the most critical and prevalent occupational disease in China at present, according to research. Studies indicate that pneumoconiosis may indeed impact the body’s phospholipid metabolism. METHODS: In this study, serum samples were taken from 46 paired participants, which included patients with pneumoconiosis and dust-exposed workers. We employed ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) technology in targeted lipidomics to investigate serum target phospholipids. Initially, a pilot study was conducted with a selection of 24 pneumoconiosis patients and 24 dust-exposed workers, using both univariate and multivariate statistical analyses to preliminarily identify significant differences in phospholipids. Subsequent to this, the remaining subjects were engaged in a validation study, wherein receiver operating characteristic (ROC) analysis was performed to further substantiate the screening potency of potential lipid biomarkers for pneumoconiosis. RESULTS: The pilot study revealed significantly reduced serum levels of 16∶0 lysophosphatidylcholines (Lyso PC), 18∶0–18∶1 phosphatidylglycerol (PG), 18∶0–18∶1 phosphatidylethanolamine (PE), 18∶0 PE, and 18∶1 lysophosphatidylethanolamine(Lyso PE) in the case group in comparison to the control group. Additionally, 18∶0 PE, 18∶0–18∶1 PE, and 18∶1 Lyso PE emerged as significant phospholipids with superior diagnostic values [area under the curve (AUC)>0.7]. A diagnostic model was established, built on 16∶0 PC and 18∶0 PE (AUC>0.8). In the ROC analyses of validation studies, the 18∶0–18∶1 PE and this diagnostic model demonstrated excellent screening efficiency (AUC>0.7). DISCUSSION: A significant divergence in phospholipid metabolism has been observed between pneumoconiosis patients and dust-exposed workers. The 18∶0–18∶1 PE present in serum could potentially function as a lipid biomarker for pneumoconiosis. Additionally, diagnostic models were developed relying on 16∶0 PC and 18∶0 PE, proving to have superior screening efficiency. Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023-09-22 /pmc/articles/PMC10560374/ /pubmed/37814648 http://dx.doi.org/10.46234/ccdcw2023.161 Text en Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Methods and Applications
Wang, Wenrong
Peng, Fangda
Ding, Chunguang
Li, Tao
Wang, Huanqiang
An Analysis of Targeted Serum Lipidomics in Patients with Pneumoconiosis — China, 2022
title An Analysis of Targeted Serum Lipidomics in Patients with Pneumoconiosis — China, 2022
title_full An Analysis of Targeted Serum Lipidomics in Patients with Pneumoconiosis — China, 2022
title_fullStr An Analysis of Targeted Serum Lipidomics in Patients with Pneumoconiosis — China, 2022
title_full_unstemmed An Analysis of Targeted Serum Lipidomics in Patients with Pneumoconiosis — China, 2022
title_short An Analysis of Targeted Serum Lipidomics in Patients with Pneumoconiosis — China, 2022
title_sort analysis of targeted serum lipidomics in patients with pneumoconiosis — china, 2022
topic Methods and Applications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560374/
https://www.ncbi.nlm.nih.gov/pubmed/37814648
http://dx.doi.org/10.46234/ccdcw2023.161
work_keys_str_mv AT wangwenrong ananalysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022
AT pengfangda ananalysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022
AT dingchunguang ananalysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022
AT litao ananalysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022
AT wanghuanqiang ananalysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022
AT wangwenrong analysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022
AT pengfangda analysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022
AT dingchunguang analysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022
AT litao analysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022
AT wanghuanqiang analysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022